Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia (Q33333991)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia |
scientific article |
Statements
1 reference
Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia (English)
1 reference
Dmoszyńska A
1 reference
Lech-Marańda E
1 reference
Robak T
1 reference
Wrzesień-Kuś A
1 reference
Kowal M
1 reference
1 September 2000
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference